Skip to main content
Top
Published in: International Journal of Clinical Oncology 6/2008

01-12-2008 | Original Article

Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo

Authors: Wataru Arai, Yoshinori Hosoya, Hidenori Haruta, Kentaro Kurashina, Shin Saito, Yuuki Hirashima, Taku Yokoyama, Toru Zuiki, Kazuya Sakuma, Masanobu Hyodo, Yoshikazu Yasuda, Hideo Nagai, Tetsuhiko Shirasaka

Published in: International Journal of Clinical Oncology | Issue 6/2008

Login to get access
Metadata
Title
Comparison of alternate-day versus consecutive-day treatment with S-1: assessment of tumor growth inhibition and toxicity reduction in gastric cancer cell lines in vitro and in vivo
Authors
Wataru Arai
Yoshinori Hosoya
Hidenori Haruta
Kentaro Kurashina
Shin Saito
Yuuki Hirashima
Taku Yokoyama
Toru Zuiki
Kazuya Sakuma
Masanobu Hyodo
Yoshikazu Yasuda
Hideo Nagai
Tetsuhiko Shirasaka
Publication date
01-12-2008
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 6/2008
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-008-0780-4

Other articles of this Issue 6/2008

International Journal of Clinical Oncology 6/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine